FSLR
58
3
XEL
39
2
MO
51
-6
ADSK
62
6
HSIC
67
2
CCI
34
-2
CL
56
-6
STZ
44
-3
LMT
55
-4
UNP
36
-3
ADP
58
-8
ADT
48
-2
CHRW
79
3
AN
43
-6
AME
66
4
STI
7
2
CNX
46
-3
CME
42
-8
JBHT
63
3
PAYX
32
-4
FSLR
58
3
XEL
39
2
MO
51
-6
ADSK
62
6
HSIC
67
2
CCI
34
-2
CL
56
-6
STZ
44
-3
LMT
55
-4
UNP
36
-3
ADP
58
-8
ADT
48
-2
CHRW
79
3
AN
43
-6
AME
66
4
STI
7
2
CNX
46
-3
CME
42
-8
JBHT
63
3
PAYX
32
-4
Financhill
Back

Gabelli Financial Services Opportunities ETF Vs. Rhythm Pharmaceuticals, Inc. Sector Stock Comparison

Sell
28

GABF
Gabelli Financial Services Opportunities ETF

Last Price:
$47.04
Seasonality Move:
-0.61%
Sell
44

RYTM
Rhythm Pharmaceuticals, Inc.

Last Price:
$112.11
Seasonality Move:
-13.08%
Sell
28
Gabelli Financial Services Opportunities ETF (GABF) is a Sell

Is Gabelli Financial Services Opportunities ETF a Buy, Sell or Hold?

  • The current Gabelli Financial Services Opportunities ETF [GABF] share price is $47.00. The Score for GABF is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • GABF is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
44
Rhythm Pharmaceuticals, Inc. (RYTM) is a Sell

Is Rhythm Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Rhythm Pharmaceuticals, Inc. [RYTM] share price is $111.73. The Score for RYTM is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • RYTM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GABF Stock Price Chart

What is Gabelli Financial Services Opportunities ETF's stock price today?

RYTM Stock Price Chart

What is Rhythm Pharmaceuticals, Inc.'s stock price today?

  • The Rhythm Pharmaceuticals, Inc. share price today is $111.73
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing slight buying pressure.

GABF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.26 Buy
Relative Strength Index (14 RSI): 54.46 Buy
Chaikin Money Flow: -3684 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (45.07 - 47.15) Buy
Bollinger Bands (100): (46.21 - 48.69) Sell

RYTM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 15.8 Buy
Relative Strength Index (14 RSI): 56.8 Buy
Chaikin Money Flow: 32783 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (100.63 - 111.03) Buy
Bollinger Bands (100): (95.29 - 108.53) Buy

GABF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 47.23 Sell
20-day SMA: 46.36 Buy
50-day SMA: 46.51 Buy
200-day SMA: 46.12 Buy
8-day EMA: 47.02 Sell
20-day EMA: 46.68 Buy
50-day EMA: 46.72 Buy
200-day EMA: 46.31 Buy

RYTM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 110.65 Buy
20-day SMA: 107.3 Buy
50-day SMA: 106.17 Buy
200-day SMA: 82.91 Buy
8-day EMA: 44.16 Buy
20-day EMA: 20.28 Buy
50-day EMA: 8.6 Buy
200-day EMA: 2.21 Buy

Gabelli Financial Services Opportunities ETF Earnings Growth & GABF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Rhythm Pharmaceuticals, Inc. Earnings Growth & RYTM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.99 per share, and an increase next year of $0.47 per share.

Gabelli Financial Services Opportunities ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Rhythm Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):